Evidence map›Paper›PMID 42360666›Full record

ArticleMedical oncology (Northwood, London, England)2026

Targeting and monitoring cancer cells with cold atmospheric plasma and PET Imaging: a new theranostic approach.

Shokoufeh Karimi, Hasan Mehdian, Shahzad Feizi, Ali Hasanbeigi, Saeed Rajabifar

Abstract read
PubMed Publisher
In one paragraph

Article in Medical oncology (Northwood, London, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Shokoufeh KarimiDepartment of Physics, Institute for plasma research, Kharazmi University, P.O.Box 15614, Tehran, Iran.
Hasan MehdianDepartment of Physics, Institute for plasma research, Kharazmi University, P.O.Box 15614, Tehran, Iran.
Shahzad FeiziRadiation Application Research School, Nuclear Science and Technology Research Institute (NSTRI), P.O. Box 31485-498, Karaj, Iran. sfeizi@aeoi.org.ir.
Ali HasanbeigiDepartment of Physics, Institute for plasma research, Kharazmi University, P.O.Box 15614, Tehran, Iran.
Saeed RajabifarRadiation Application Research School, Nuclear Science and Technology Research Institute (NSTRI), P.O. Box 31485-498, Karaj, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cold atmospheric plasma (CAP) has emerged as a promising tool for biomedical applications, including cancer research. In this study, we developed a micro‑sized CAP device designed for minimally painful subdermal plasma delivery in BALB/c mice without the need for anesthesia. The in vitro effects of CAP were evaluated in 4T1 breast cancer cells, and in vivo responses were assessed in tumor‑bearing mice. To quantitatively monitor treatment outcomes,

Indexed as

Breast NeoplasmsPlasma GasesPositron-Emission TomographyTheranostic NanomedicineAnimalsCell Line, TumorFemaleFluorodeoxyglucose F18HumansMiceMice, Inbred BALB CRadiopharmaceuticalsFluorodeoxyglucose F18Plasma GasesRadiopharmaceuticals18F-FDGBreast cancerCold atmospheric plasmaPETTherapyTumor

Identifiers

PMID42360666

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.